---
title: "Network meta-analysis using survival data"
author: "Nathan Green"
institute: Department of Statistic Science | University College London
format:
  revealjs:
    slide-number: true
    progress: true
    controls: true
    theme: simple
    fontsize: 1.8em
    margin: 0.07
    height: 900
    footer: "NMA with survival data | Nathan Green (UCL)"
# format: beamer
---

## Summary

* Recap part one
  * Basic NMA with binary data
  
* NMA with survival data
  * IPD time to event
  * Contrast-based data hazard ratios (HR)

* BUGS with R practical

::: {.callout-note icon=false}

## References

1. __Saramago P, Chuang LH, Soares MO__. _Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data_. BMC Med Res Methodol. 2014;14(1). 

2. __Woods BS, Hawkins N, Scott DA__. _Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial_. BMC Med Res Methodol. 2010;10. 
:::

## Recap of part 1

* Unusual for a policy question to be informed by a single study
  * Must use all available and relevant evidence

::: {.incremental}
- New treatment C: been trialled against old treatment B, but not to A

- For health economic evaluation need to compare A/B/C together

- Learn about C/A effect from C/B and B/A trial data

- Also called "mixed treatment comparisons". Since can also “mix” direct and indirect data on same comparison...
:::

## Count data equations

::: {.callout-note icon=false}

## Fixed effects

$$
r_{st} \sim Bin(p_{st}, n_{st})\\
logit(p_{st}) = \mu_s + \delta_{st}\\
\delta_{st} \sim d_t - d_{t_{s0}}
$$

:::

::: {.callout-note icon=false}

## Random effects

$$
r_{st} \sim Bin(p_{st}, n_{st})\\
logit(p_{st}) = \mu_s + \delta_{st}\\
\delta_{st} \sim N(\mu^{\delta}_{st}, \sigma^2_{st})\\
\mu^{\delta}_{st} \sim d_t - d_{t_{s0}}
$$

:::


## More realistic situation

* Different types of data we want to synthesise.

## Binary data with time to event data (TTE)

* Use example from Saramago (2014)^[__Saramago P, Chuang LH, Soares MO__. _Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data_. BMC Med Res Methodol. 2014;14(1).]

. . .

* The case study relates to compression systems aiming to deliver high compression to promote venous leg ulcer healing

. . .

* The final NMA contained data from 16 RCTs
  * 2 included RCTs had full IPD data  (841 participants) which included time to healing or censoring for each participant, together with other characteristics (treatment centre, ulcer duration, size,  patient mobility).
  * Remaining aggregate data only
  

::: aside

:::

## Data

![](paper-table.png){width=300, fig-align="centre"}

## Network diagram

![](paper-network-diagram.png){fig-align="centre"}

## IPD model

* $i$th participant in $j$th study in $k$th treatment arm

$$
t_{ijk} \sim Weibull(s, \lambda_{ijk}) I(t^c_{ijk})
$$


$$
\log(\lambda_{ijk}) = 
\begin{cases}
    \mu_j^{IPD} + \gamma_j^c + \beta_{0j}x_{ijk}, & \text{if } k=b\\
    \mu_j^{IPD} + d_{bk} + \gamma_j^c + \beta_{0j}x_{ijk}, & \text{if } k \gt b
\end{cases}
$$


$$
x_{ijk} \sim N(m,p) \;\;\; \gamma^c_j \sim N(0, \pi)
$$

## AD model

* The linear predictor, $\log(\lambda^{AD}_{jk})$ was a function of the baseline log-hazard of an event for treatment $b$ in study $j$, $\mu^{AD}_{jb}$, and by the log-hazard ratio for treatment $k$ and baseline treatment $b$, $d_{bk}$ (= $d_{1k} − d_{1b}$).
Note that there are parameters common to both model parts, namely the log-hazard ratios and the shape parameter of the time to healing distribution.

$$
r_{jk} \sim Bin(p_{jk}, n_{nk})
$$

$$
p_{jk} = 1 - \exp(- \lambda_{jk}^{AD} {(t^{AD}_{jk})}^s)
$$

$$
\log(\lambda_{jk}^{AD}) =
\begin{cases}
    \mu_j^{AD}, & \text{if } k=b\\
    \mu_j^{AD} + d_{bk}, & \text{if } k \gt b
\end{cases}
$$

## Data format

-   `treat`: treatment arm (coded 1,2)

-   `baseline`: reference treatment code, 

-   `t.obs`: time to event in months (under censoring)

-   `t.cens`: time of censoring in months,

-   `n.subjects`: Number of participants in IPD

-   `n.treat`: Number of treatments

-   `a.id` : study number

-   `a.treat` : treatment arm code (coded from 1 to number of treatments), 

-   `r` : number of events in trial arm

-   `n` : number of patients in trial arm

-   `a.base` : reference treatment code

-   `a.time` : follow-up time of trial

-   `n.agg.trials` : Number of AD studies

-   `n.agg.arms` : Number of AD study arms


## Data format

```{r}
#| echo: true

load(here::here("part 2/practical/tte_counts_input_data.RData"))

input_dat
```

## Coding in BUGS

* [Part 1]{style="color: red"}: Model for IPD

```{r eval=FALSE, echo=TRUE}
#| code-line-numbers: "|5-6|8-9|"

model {
  ### Part 1: Model for IPD
  
  for(i in 1:n.subjects) {
    # Weibull likelihood for IPD
    t.obs[i] ~ dexp(zu[i])I(t.cens[i], )
    
    # Model for IPD
    log(zu[i]) <- mu + d[treat[i]] - d[baseline[i]]
  }
  
  # Vague prior for IPD
  mu ~ dnorm(0, 1.0E-6)
```

## Coding in BUGS

* [Part 2]{style="color: red"}: Model for aggregate data

```{r eval=FALSE, echo=TRUE}
#| code-line-numbers: "|4-5|7-9|"

  ### Part 2: Model for aggregate data
  
  for (i in 1:n.agg.arms) {
    # Binomial likelihood for AD
    r[i] ~ dbin(pa[i], n[i])
    
    # Model for AD
    pa[i] <- 1 - exp(-zu.a[i] * a.time[i])
    log(zu.a[i]) <- mu.a[a.id[i]] + d[a.treat[i]] - d[a.base[i]]
  }
  
  # Vague priors for AD
  for(j in 1:n.agg.trials) {
    mu.a[j] ~ dnorm(0, 1.0E-6)
  }
```

## Coding in BUGS

* [Part 3]{style="color: red"}: Model for combining all estimates of treatment effect

```{r eval=FALSE, echo=TRUE}
  ### Model for combining all estimates of treatment effect
  
  # Vague prior for basic parameters
  d[1] <- 0
  
  for (k in 2:n.treat) {
    d[k] ~ dnorm(0, 1.0E-6)
  }
}
```

## Binary data with contrast-based survival data

* Use example from Woods (2010)^[__Woods BS, Hawkins N, Scott DA__. _Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial_. BMC Med Res Methodol. 2010;10. ]

. . .

* Data on survival endpoints are usually summarised using either _hazard ratio_, _cumulative number of events_, or _median_ survival statistics

. . .

* NMA of survival endpoints can combine count and hazard ratio statistics in a single analysis on the hazard ratio scale

. . .

* A worked example of an analysis of mortality data in chronic obstructive pulmonary disease (COPD)

::: aside

:::


## Data

* Input RCT data binary counts table

![](woods-count-table.png){width=400, fig-align="centre"}

* Input RCT hazard summary table

![](woods-hr-table.png){width=400, fig-align="centre"}


## Count statistics on log-hazard ratio scale

* For $r_{sk}$ is the cumulative count of subject who have experienced an event in arm $k$ of study $s$; $n_{sk}$ is total number of subjects in arm $k$ of study $s$ and $F_{sk}$ is the cumulative probability of subject having an event.

$$
r_{sk} \sim Bin(F_{sk}, n_{sk})
$$

* The log cumulative hazard for each trial arm is then

$$
\ln(H_{sk}) = \ln(-\ln(1-F_{sk}))
$$

* The log cumulative hazard is estimated as the sum of a study specific ‘baseline’ term $\alpha_s$ and a treatment effect coefficient $\beta_k$:

$$
\ln(H_{s,k}) = \alpha_s + \beta_k - \beta_b
$$
where $\beta_1 = 0$ for the reference treatment and $\beta_b$ represents the treatment effect for the baseline treatment in study $s$.

## What is $\beta_k$?

* Under the assumption of proportional hazards, $\beta_k$ is _both_ log cumulative hazard ratio _and_ log hazard ratio:

$$
\ln \left( \frac{\exp(\beta_k) h_{sb}}{h_{sb}} \right) = \ln \left( \frac{\int_0^t\exp(\beta_k) h_{sb}}{\int_0^th_{sb}} \right) = \beta_k
$$

## Combining count and hazard ratio statistics in an NMA

* $x_{skb}$ is log hazard ratio estimate for study $s$ comparing treatments $k$ and $b$

$$
x_{skb} \sim N \left( \ln\left( \frac{h_{sk}}{h_{sb}} \right), se^2_{skb} \right)
$$
then

$$
\ln\left( \frac{h_{sk}}{h_{sb}} \right) = \beta_k - \beta_b
$$

## Coding in BUGS

* For hazard ratio reporting studies

```{r eval=FALSE, echo=TRUE}

for (ii in 1:LnObs) {
  Lmu[ii] <- alpha[Lstudy[ii]]*multi[ii] + beta[Ltx[ii]] - beta[Lbase[ii]]
  Lprec[ii] <- 1 / pow(Lse[ii], 2)
  Lmean[ii] ~ dnorm(Lmu[ii], Lprec[ii])
}
```

* For binary data reporting studies

```{r eval=FALSE, echo=TRUE}

for (ss in 1:BnObs) {
  logCumHaz[ss] <- alpha[Bstudy[ss]] + beta[Btx[ss]] - beta[Bbase[ss]]
  cumFail[ss] <- 1 - exp(-1 * exp(logCumHaz[ss]))
  Br[ss] ~ dbin(cumFail[ss], Bn[ss])
  }
  
```


## Going further


::: {.callout-note icon=false}

## References

1. __Saramago P, Chuang LH, Soares MO__. _Network meta-analysis of (individual patient) time to event data alongside (aggregate) count data_. BMC Med Res Methodol. 2014;14(1). 

2. __Woods BS, Hawkins N, Scott DA__. _Network meta-analysis on the log-hazard scale, combining count and hazard ratio statistics accounting for multi-arm trials: A tutorial_. BMC Med Res Methodol. 2010;10.

3. __Donegan S, Williamson P, D’Alessandro U, Garner P, Smith C__: _Combining individual patient data and aggregate data in mixed treatment comparison meta-analysis: individual patient data may be beneficial if only for a subset of trials_. Stat Med 2013, 32(6):914–930.

4. __Berlin J, Santanna J, Schmid C, Szczech L, Feldman H__: _Individual patient- versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head_. Stat Med 2002, 21(3):371–387.

5. __Riley R, Lambert P, Staessen J, Wang J, Gueyffier F, Thijs L, Boutitie F__: _Meta-analysis of continuous outcomes combining individual patient data and aggregate data_. Stat Med 2008, 27(11):1870–1893

:::


<!-- template code -->

<!-- :::: {.columns} -->

<!-- ::: {.column width="50%"} -->

<!-- ::: -->

<!-- ::: {.column width="50%"} -->

<!-- ::: -->

<!-- :::: -->
